Diabetes mellitus and obesity as risk factors for pancreatic cancer

G Eibl, Z Cruz-Monserrate, M Korc, MS Petrov… - Journal of the Academy …, 2018 - Elsevier
Pancreatic ductal adenocarcinoma (PDAC) is among the deadliest types of cancer. The
worldwide estimates of its incidence and mortality in the general population are eight cases …

Nonsteroidal anti‐inflammatory therapy: a journey toward safety

C Pereira‐Leite, C Nunes, SK Jamal… - Medicinal research …, 2017 - Wiley Online Library
The efficacy of nonsteroidal anti‐inflammatory drugs (NSAIDs) against inflammation, pain,
and fever has been supporting their worldwide use in the treatment of painful conditions and …

NLRP3 inflammasome activation promotes inflammation-induced carcinogenesis in head and neck squamous cell carcinoma

CF Huang, L Chen, YC Li, L Wu, GT Yu… - Journal of Experimental …, 2017 - Springer
Background NLRP3 inflammasome acts as a danger signal sensor that triggers and
coordinates the inflammatory response. However, the roles of NLRP3 inflammasome in the …

Resistance to gemcitabine in pancreatic ductal adenocarcinoma: A physiopathologic and pharmacologic review

T Koltai, SJ Reshkin, TMA Carvalho, D Di Molfetta… - Cancers, 2022 - mdpi.com
Simple Summary PDAC is one of the most malignant tumors and its treatment, whether
surgery or chemotherapy, has shown poor results. Resistance to gemcitabine and other …

Targeting cancer stem cells for chemoprevention of pancreatic cancer

D Subramaniam, G Kaushik… - Current Medicinal …, 2018 - ingentaconnect.com
Pancreatic ductal adenocarcinoma is one of the deadliest cancers worldwide and the fourth
leading cause of cancer-related deaths in United States. Regardless of the advances in …

Tuft cells: From the mucosa to the thymus

S Nevo, N Kadouri, J Abramson - Immunology letters, 2019 - Elsevier
Tuft cells are epithelial chemosensory cells with unique morphological and molecular
characteristics, the most noticeable of which is a tuft of long and thick microvilli on their …

[HTML][HTML] Patient-derived tumor models are attractive tools to repurpose drugs for ovarian cancer treatment: Pre-clinical updates

M Cybula, M Bieniasz - Oncotarget, 2022 - ncbi.nlm.nih.gov
Despite advances in understanding of ovarian cancer biology, the progress in translation of
research findings into new therapies is still slow. It is associated in part with limitations of …

Functional implication of Dclk1 and Dclk1-expressing cells in cancer

CB Westphalen, M Quante, TC Wang - Small GTPases, 2017 - Taylor & Francis
Doublecortin like kinase protein 1 (Dclk1) is a microtubule-associated protein with C-
terminal serine/threonine kinase domain. Originally designated Doublecortin and CaM …

Loss of natural killer T cells promotes pancreatic cancer in LSL‐KrasG12D/+ mice

NB Janakiram, A Mohammed, T Bryant, R Ritchie… - …, 2017 - Wiley Online Library
The role of the unique T‐cell population, natural killer T (NKT) cells, which have similar
functions to NK cells in pancreatic cancer (PC), is not yet evaluated. To address the …

[HTML][HTML] Repositioning antipsychotic chlorpromazine for treating colorectal cancer by inhibiting sirtuin 1

WY Lee, WT Lee, CH Cheng, KC Chen, CM Chou… - Oncotarget, 2015 - ncbi.nlm.nih.gov
Investigating existing drugs for repositioning can enable overcoming bottlenecks in the drug
development process. Here, we investigated the effect and molecular mechanism of the …